A Phase 1, Open-label, Single-dose, Randomized, 4-treatment, 4- Period, Crossover, Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bza/Conjugated Estrogens in Healthy Postmenopausal Women
Phase of Trial: Phase I
Latest Information Update: 17 Jan 2013
At a glance
- Drugs Bazedoxifene (Primary) ; Conjugated estrogens/bazedoxifene
- Indications Postmenopausal osteoporosis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 17 Jan 2013 Actual initiation date changed from Jul 2012 to Aug 2012 as reported by ClinicalTrials.gov.
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.